Tell-tale immune-related neurological syndromes: Should we look for and underlying low-grade B-cell lymphoma? A retrospective study on 12 cases.

Anti-MAG neuropathy Immune-mediated neurological disease Lymphoplasmacytic Lymphoma Marginal Zone Lymphoma Monoclonal gammopathy Paraproteinemic neuropathy

Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
31 May 2024
Historique:
received: 24 02 2024
accepted: 28 05 2024
medline: 9 6 2024
pubmed: 9 6 2024
entrez: 8 6 2024
Statut: aheadofprint

Résumé

Immune-related neurological syndromes (affecting both the central and peripheral nervous system, as well as the neuromuscular junction) can associate with low-grade B-cell lymphomas. We conducted a retrospective study on the records of patients with miscellaneous immune-related neuropathies followed by the "Referral Centre for Neuromuscular Diseases and ALS" in collaboration with the Services of Internal Medicine and Hematology (La Timone Hospital, and the Paoli Calmettes-Insitute, Marseille, France; Geneva University Hospitals, Geneva, Switzerland). Clinical, biological, immunological and histological work-up was carried out and data collected. We identified 12 patients with neurological syndromes and atypical presentation/course. In all these patients multiple autoantibodies were found. This prompted us to perform thorough hematologic investigations, that led to the diagnosis of different type of Low-Grade B-Cell lymphomas [i.e. marginal zone lymphomas with lymphoplasmacytic differentiation (n=3), splenic marginal area lymphoma with secondary lymph node invasion (n=1), unclassified marginal area lymphomas (n=8)]. Treatment of the underling lymphoma resulted in an improvement (n=8) or stabilization (n=4) of neurological disease. Atypical presentation of immune-related neurological syndromes, as well as the presence of antibodies with different antigenic targets should be regarded as "warning signs" and raise the suspicion of a paraneoplastic origin sustained by an underlying low-grade B-cell lymphoma that should be actively sought and treated. Close collaboration between internists, neurologists and hematologists allows for the appropriate management of each case.

Identifiants

pubmed: 38850875
pii: S0344-0338(24)00288-7
doi: 10.1016/j.prp.2024.155377
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155377

Informations de copyright

Copyright © 2024. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There is no conflict of interest.

Auteurs

Matteo Coen (M)

Division of General Internal Medicine, Department of Medicine, Hôpitaux Universitaires de Genève, Genève, Switzerland; Unit of Development and Research in Medical Education, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: matteo.coen@hug.ch.

Audrey Benyamine (A)

Service of Internal Medicine, CHU Nord, AP-HM, Marseille, France.

Emilien Delmont (E)

Referral Centre for Neuromuscular Diseases and ALS, Hôpital La Timone, Marseille, France.

Gilles Kaplanski (G)

Department of Internal Medicine and Clinical Immunology, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.

Reda Bouabdallah (R)

Department of Hematology, Hopital Privé de Provence, Aix en Provence, France.

Luc Xerri (L)

Department of Tumor Immunology, Paoli-Calmettes Institute, Marseille, France.

Shahram Attarian (S)

Referral Centre for Neuromuscular Diseases and ALS, Hôpital La Timone, Marseille, France.

Jacques Serratrice (J)

Division of General Internal Medicine, Department of Medicine, Hôpitaux Universitaires de Genève, Genève, Switzerland.

Classifications MeSH